ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DARE vs BFRI // NET PROFIT MARGIN

Dare Bioscience Inc. (NASDAQ) VS. Biofrontera Inc. (NASDAQ) • 15-METRIC TALLY: DARE 3 — BFRI 3
▲ NET PROFIT MARGIN LEADER: BFRI
net-margins
-25.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DARE VS. BFRI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DARE BFRI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 71.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -27.20% -32.80 BFRI /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% -25.30% -34.70 BFRI /net-margins <GO>
Revenue Growth (YoY) 180.00% 11.70% +168.30 DARE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 DARE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.9 42.2 +0.67 DARE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $13.4M $13.8M -$430.5K BFRI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DARE REV BFRI REV DARE GROSS % BFRI GROSS % DARE FCF BFRI FCF
FY 2025 $1.0M $41.7M 71.3% — -$10.3M -$13.4M
FY 2024 $9.8K $37.3M 98.0% — $4.9M -$10.3M
FY 2023 $2.8M $34.1M — — -$38.9M -$24.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DARE // BETA —
BFRI // BETA —